ACATOTCServices-Educational ServicesFiscal year ends December 31

NP Life Sciences Health Industry Group Inc.

Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024

$10.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $429.60M
P/E (TTM): –
Dividend yield: –

NP Life Sciences Health Industry Group Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	0.16	0.10	0.03	0.02	0.04
General & Administrative	0.17	0.12	0.10	0.15	0.15
Operating Income	0.00	-0.02	-0.07	-0.13	-0.11
Interest Expense	0.00	0.00	–	–	–
Interest & Investment Income	–	–	0.00	0.00	0.00
Other Non-Operating Income	–	0.00	0.00	–	–
Pretax Income	0.00	-0.02	-0.07	-0.13	-0.11
Income Tax Expense	0.00	–	–	–	–
Net Income incl. Noncontrolling Interests	0.00	-0.02	–	–	–
Net Income	0.00	-0.02	-0.07	-0.13	-0.11
EPS (Basic)(per share)	0.00	0.00	0.00	0.00	0.00
EPS (Diluted)(per share)	0.00	0.00	0.00	0.00	0.00
Shares Outstanding (Basic, Weighted)(shares)	43	43	43	43	34
Shares Outstanding (Diluted, Weighted)(shares)	43	43	43	43	34
Net Interest Income	–	0.00	0.00	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2023

Profitability, TTM

Gross margin: –
Operating margin: -0.4%
Net margin: -1.8%
Return on equity, FY2023: –

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 185.2%

Valuation

P/E ratio: –
Price to sales: 2609.60
Price to book: –
Dividend yield: –